2015
DOI: 10.1016/s0016-5085(15)33416-8
|View full text |Cite
|
Sign up to set email alerts
|

1008 Decreased Fecal Microbial Metabolite Enterolactone is a Novel Inflammatory and Oxidative Stress Related Biomarker of Alcoholic Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It has been found to inhibit ß-oxidation and intracellular lipid metabolism, contributing to the progression of NAFLD [ 62 ]. Reduced fecal microbial metabolite enterolactone is considered a novel biomarker associated with inflammatory and oxidative stress in alcoholic liver disease [ 63 ]. Therefore, the increased content of ENL in the flaxseed lignan group suggests that flaxseed lignan attenuates PAM-induced hepatotoxicity by improving oxidative state and fatty acid metabolism.…”
Section: Discussionmentioning
confidence: 99%
“…It has been found to inhibit ß-oxidation and intracellular lipid metabolism, contributing to the progression of NAFLD [ 62 ]. Reduced fecal microbial metabolite enterolactone is considered a novel biomarker associated with inflammatory and oxidative stress in alcoholic liver disease [ 63 ]. Therefore, the increased content of ENL in the flaxseed lignan group suggests that flaxseed lignan attenuates PAM-induced hepatotoxicity by improving oxidative state and fatty acid metabolism.…”
Section: Discussionmentioning
confidence: 99%